Next Article in Journal
COVID-19 Vaccination Willingness and Acceptability in Multiple Sclerosis Patients: A Cross Sectional Study in Iran
Next Article in Special Issue
COVID-19 Vaccination Safety and Tolerability in Patients Allegedly at High Risk for Immediate Hypersensitivity Reactions
Previous Article in Journal
Antibody Levels at 3-Years Follow-Up of a Third Dose of Measles-Mumps-Rubella Vaccine in Young Adults
Previous Article in Special Issue
Atypical Kawasaki Disease after COVID-19 Vaccination: A New Form of Adverse Event Following Immunization
 
 
Case Report

Article Versions Notes

Vaccines 2022, 10(1), 134; https://doi.org/10.3390/vaccines10010134
Action Date Notes Link
article pdf uploaded. 17 January 2022 14:58 CET Version of Record https://www.mdpi.com/2076-393X/10/1/134/pdf-vor
article xml file uploaded 18 January 2022 04:19 CET Original file -
article xml uploaded. 18 January 2022 04:19 CET Update -
article pdf uploaded. 18 January 2022 04:19 CET Updated version of record https://www.mdpi.com/2076-393X/10/1/134/pdf-vor
article html file updated 18 January 2022 04:20 CET Original file -
article xml file uploaded 18 January 2022 12:52 CET Update -
article xml uploaded. 18 January 2022 12:52 CET Update https://www.mdpi.com/2076-393X/10/1/134/xml
article pdf uploaded. 18 January 2022 12:52 CET Updated version of record https://www.mdpi.com/2076-393X/10/1/134/pdf
article html file updated 18 January 2022 12:53 CET Update -
article html file updated 31 July 2022 04:18 CEST Update https://www.mdpi.com/2076-393X/10/1/134/html
Back to TopTop